*IF* they uplist. Which is very unusual for the VAST majority of companies on the OTC. Frankly, at this point I don't see a path for them to reach the OCTQB or QX, let alone uplist to a major exchange.
I'm not asking the company for a million in sales yesterday. I'm asking them to explain the discrepancy in sales numbers between their own last two quarterly reports. Something any business bothering to report (whether OTC or not) SHOULD have already planned to explain PRIOR to the report coming out, unless they don't care at all about shareholders (ding ding ding!).
There's a strong discrepancy between what the company has reported they're doing in distribution (growing exponentially into thousands of retail outlets) and what the Q shows they're doing in sales.
There are two reasons why this might happen:
1. The company didn't receive sales revenue in the way investors anticipated for that Q, even though the distribution increased.
2. The company is presenting additional distribution outlets as increasing sales when it's not.
It's in the company's best interest to convince shareholders #2 is not the case (unless it actually is the case). Since the company isn't doing that, there's a big red flag here. That red flag won't go away and the pps will continue to plummet until the company takes action to alleviate those fears.
If you love losing money, feel free to "chill out". As I've stated previously, I won't get back in until they fix this issue, because the pps will continue to drop.
News 
Market Data 
Discover 
AI
